PR PolyResearch
Join Free
NASDAQ

NewAmsterdam Pharma Company N.V. - Warrant (NAMSW)

♥ 643 Thanks from members

NewAmsterdam Pharma Company N.V. Warrants (NAMSW) present a bifurcated sentiment profile: strong institutional holding support and positive regulatory momentum for obicetrapib counterbalance widening net losses, declining short-term revenues, and major late-stage trial milestones extending into late 2026 and early 2027.

No chart available for this instrument.
Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ
GraniteShares 2x Long AAPL Daily ETF (AAPB)
NASDAQ
Apple Inc. (AAPL)
NASDAQ
Direxion Daily AAPL Bear 1X ETF (AAPD)
NASDAQ
Ascentage Pharma Group International - American Depository Shares (AAPG)
NASDAQ
Direxion Daily AAPL Bull 2X ETF (AAPU)
NASDAQ
Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)